Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Breast Cancer Research : BCR|April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implicationsClaudio Vernieri, Francesca Corti, Federico Nichetti, et al.
ESMO Open|November 7, 2020
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT studyFederico Nichetti, Marta Bini, Margherita Ambrosini, et al.
Frontiers in Oncology|September 5, 2022
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groinEmma Zattarin, Federico Nichetti, Francesca Ligorio, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
World Journal of Clinical Cases|December 18, 2014
Role of MGMT as biomarker in colorectal cancerAlessandro Inno, Giuseppe Fanetti, Maria Di Bartolomeo, et al.
Oncology Research and Treatment|March 6, 2019
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective AnalysisGiulia Galli, Stefano Cavalieri, Lorenza Di Guardo, et al.
Tumori|July 9, 2025
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridizationDaniele Lorenzini, Rebecca Salvatori, Chiara Costanza Volpi, et al.
The Pharmacogenomics Journal|February 5, 2019
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?Federico Nichetti, Felicia Stefania Falvella, Rosalba Miceli, et al.
Cancers|December 29, 2019
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer PatientsFederico Nichetti, Francesca Ligorio, Emma Zattarin, et al.
Cancers|April 10, 2019
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-AnalysisSara Pusceddu, Michele Ghidini, Martina Torchio, et al.
Pageof 8